SCHEMBL798140

SCHEMBL798140

Fc1ccc(Cc2nc3c(N4CCNCC4)nc([AsH2])nc3s2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR3A P46098 1/20 0.37
HTR6 P50406 2/20 0.36
SOS1 Q07889 1/20 0.35
HRH4 Q9H3N8 2/20 0.34
HRH3 Q9Y5N1 1/20 0.34
ADORA2A P29274 1/20 0.34
ALDH1A1 P00352 2/20 0.34
CYP1A2 P05177 2/20 0.34
CYP3A4 P08684 2/20 0.34
CYP2C9 P11712 2/20 0.34
HSD17B10 Q99714 2/20 0.34
ITGA2B P08514 2/20 0.34
CASP1 P29466 1/20 0.34
CASP7 P55210 1/20 0.34
CSNK1A1 P48729 1/20 0.34
OPRL1 P41146 1/20 0.34
PRKCI P41743 2/20 0.33
NPY5R Q15761 1/20 0.33
HTR2C P28335 1/20 0.33
HTR2B P41595 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL798130 0.88 HTR3A (0.35) HTR3AHTR6SOS1HRH4HRH3
SCHEMBL798084 0.88 HTR3A (0.35) HTR3AHTR6SOS1HRH4HRH3
SCHEMBL656382 0.87 HRH4 (0.46) HTR3AHTR6HRH4HRH3
SCHEMBL1720807 0.81 HRH4 (0.46) HTR6HRH4HRH3CYP3A4
SCHEMBL654836 0.77 HRH4 (0.45) HTR3AHTR6HRH4HRH3
SCHEMBL656370 0.75 HRH4 (0.43) HTR3AHTR6HRH4HRH3
SCHEMBL655227 0.75 HRH4 (0.43) HTR3AHTR6HRH4HRH3
SCHEMBL655975 0.74 ADORA2A (0.49) HTR3AHTR6ADORA2AALDH1A1CYP1A2
SCHEMBL654939 0.73 NOS1 (0.39) HTR6HRH4ALDH1A1
SCHEMBL1720675 0.70 ADORA2A (0.44) HTR6HRH4HRH3ADORA2AHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2616077-A1 ANTI-CANCER ACTIVITY OF NOVEL BICYCLIC HETEROCYCLES Katholieke Universiteit Leuven, K.U. Leuven R&D (BE) 2013-07-24 EP disclosed
WO-2012035423-A1 ANTI-CANCER ACTIVITY OF NOVEL BICYCLIC HETEROCYCLES KATHOLIEKE UNIVERSITEIT LEUVEN, K.U. LEUVEN R&D (BE) 2012-03-22 WO disclosed